• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化的基本条件对于将小干扰RNA(siRNA)成功转染到原代内皮细胞中至关重要。

Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells.

作者信息

Nolte Andrea, Raabe Claudia, Walker Tobias, Simon Perikles, Ziemer Gerhard, Wendel Hans Peter

机构信息

Department of Thoracic, Cardiac, and Vascular Surgery, Division of Sports Medicine, University Hospital Tübingen, Tübingen, Germany.

出版信息

Oligonucleotides. 2009 Jun;19(2):141-50. doi: 10.1089/oli.2009.0182.

DOI:10.1089/oli.2009.0182
PMID:19441891
Abstract

RNA interference (RNAi) is a powerful technique in basic research and has a high potential for therapeutic applications. To realize its clinical applicability, introduction of short double-stranded RNA (dsRNA) has to be carried out under physiological conditions. This study evaluates two cationic liposomal transfection reagents on the efficiency of successful silencing of primary human endothelial cells. Transfection efficiency was investigated under different conditions, for example different media during transfection, duration of transfection, siRNA concentration, and the use of serum and antibiotics. Viability after transfection was examined by CASY and MTT assay. Interferon response was examined by real-time PCR. First we revealed that transfection carried out in the presence of serum and antibiotics caused good knockdown results only by the use of the novel lipid cationic transfection reagent. Both lipid cations had slightly the same transfection efficiency over the range of 10-150 nM siRNA concentration. Examination of interferon response showed increasing OAS1 and STAT1 expression, but not as high as if the transfections were carried out with synthetic polyinosinic-polycytidylic acid double-stranded RNA (poly[IC]). The optimized combination of basic conditions for transfection significantly enhanced the efficiency of the siRNA-mediated knockdown, without causing toxicity or stimulation of the interferon pathway.

摘要

RNA干扰(RNAi)是基础研究中的一项强大技术,在治疗应用方面具有很高的潜力。为了实现其临床适用性,必须在生理条件下引入短双链RNA(dsRNA)。本研究评估了两种阳离子脂质体转染试剂对原代人内皮细胞成功沉默效率的影响。在不同条件下研究转染效率,例如转染期间的不同培养基、转染持续时间、siRNA浓度以及血清和抗生素的使用。通过CASY和MTT测定法检测转染后的活力。通过实时PCR检测干扰素反应。首先,我们发现仅使用新型脂质阳离子转染试剂时,在血清和抗生素存在下进行的转染才能产生良好的敲低效果。在10 - 150 nM siRNA浓度范围内,两种脂质阳离子的转染效率略有相同。干扰素反应检测显示OAS1和STAT1表达增加,但不如用合成的聚肌苷酸 - 聚胞苷酸双链RNA(聚[IC])进行转染时高。转染基本条件的优化组合显著提高了siRNA介导的敲低效率,且不会引起毒性或刺激干扰素途径。

相似文献

1
Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells.优化的基本条件对于将小干扰RNA(siRNA)成功转染到原代内皮细胞中至关重要。
Oligonucleotides. 2009 Jun;19(2):141-50. doi: 10.1089/oli.2009.0182.
2
[Research on cationic vector-mediated RNAi].[阳离子载体介导的RNA干扰研究]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Aug;29(4):722-6.
3
Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells.细胞类型和转染试剂对人原代间充质细胞中RNAi的活力、细胞含量、细胞周期及炎症的依赖性影响。
Eur J Pharm Sci. 2014 Mar 12;53:35-44. doi: 10.1016/j.ejps.2013.12.006. Epub 2013 Dec 15.
4
Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.新型阳离子 Gemini 生育酚脂质介导的 survivin 下调在血清中实现有效基因沉默并诱导显著的凋亡活性。
Mol Pharm. 2015 Feb 2;12(2):351-61. doi: 10.1021/mp500620e. Epub 2014 Dec 18.
5
Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons.“裸”小干扰RNA转染导致培养神经元的内吞摄取及代谢损伤。
Biochem Biophys Res Commun. 2004 Mar 19;315(4):1126-33. doi: 10.1016/j.bbrc.2004.01.170.
6
Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.小干扰RNA的脂质载体:与质粒DNA在制剂、细胞摄取及递送方面的差异
Biochemistry. 2004 Oct 26;43(42):13348-56. doi: 10.1021/bi048950a.
7
A peptidomimetic siRNA transfection reagent for highly effective gene silencing.一种用于高效基因沉默的拟肽 siRNA 转染试剂。
Mol Biosyst. 2006 Jun;2(6-7):312-7. doi: 10.1039/b603229j. Epub 2006 May 17.
8
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.使用Lipofectamine 2000试剂进行高级转染:原代神经元、小干扰RNA及高通量应用。
Methods. 2004 Jun;33(2):95-103. doi: 10.1016/j.ymeth.2003.11.023.
9
SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.圣脂质体-聚阳离子颗粒,一种用于改善小干扰RNA向炎症内皮细胞递送的新型载体。
Eur J Pharm Biopharm. 2015 Jan;89:40-7. doi: 10.1016/j.ejpb.2014.11.015. Epub 2014 Nov 25.
10
Optimization of Transfection Conditions for siRNA Screening.
Methods Mol Biol. 2016;1470:15-24. doi: 10.1007/978-1-4939-6337-9_2.

引用本文的文献

1
Isolation of Primary Mouse Lung Endothelial Cells.原代鼠肺内皮细胞的分离。
J Vis Exp. 2021 Nov 10(177). doi: 10.3791/63253.
2
RNA-Eluting Surfaces for the Modulation of Gene Expression as A Novel Stent Concept.用于调节基因表达的RNA洗脱表面作为一种新型支架概念
Pharmaceuticals (Basel). 2017 Feb 10;10(1):23. doi: 10.3390/ph10010023.
3
New basic approach to treat non-small cell lung cancer based on RNA-interference.基于 RNA 干扰的治疗非小细胞肺癌的新基础方法。
Thorac Cancer. 2014 Mar;5(2):112-20. doi: 10.1111/1759-7714.12065. Epub 2014 Mar 3.
4
Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing.小干扰 RNA 洗脱表面作为一种新型的血管内局部基因沉默的概念。
Mol Med. 2011;17(11-12):1213-22. doi: 10.2119/molmed.2011.00143. Epub 2011 Jul 22.
5
Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors.小干扰RNA 3'端突出对胸苷酸合成酶抑制剂化学敏感性的影响。
Silence. 2011 Jan 19;2(1):1. doi: 10.1186/1758-907X-2-1.